Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

2 Visualizzazioni
administrator
administrator
09/30/23

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

  • Categoria

Mostra di più

0 Commenti Ordina per

Nessun commento trovato

Commenti su Facebook

Avanti il prossimo